+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neuroscience Market Size, Share & Trends Analysis Report By Component (Instruments, Consumables), By Technology (Neuro-Microscopy, Brain Imaging), By End-user (Hospitals, Diagnostic Laboratories), And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 117 Pages
  • August 2023
  • Region: Global
  • Grand View Research
  • ID: 5876207
The global neuroscience market size is expected to reach USD 65.2 billion by 2030, growing at a CAGR of 5.56% from 2023 to 2030. This growth can be attributed to the increasing incidence of chronic neurological disorders. Stroke, epilepsy, multiple sclerosis, dementia, Parkinson’s disease, and other disorders are major contributors to the high neurological disease burden. According to World Stroke Organization (WSO), more than 12.2 million incidences of stroke are reported yearly. In addition, it is estimated that, globally, one in four people above the age of 25 years will suffer from a stroke in their lifetime. Thus, the increasing prevalence of stroke is projected to propel the demand for devices associated with it, thereby driving market growth.

Furthermore, there is an increase in the interest of manufacturers in supporting research and development (R&D) to launch novel and technologically advanced neurovascular interventional devices, such as aspiration catheters and clot retrieval devices. In January 2023, Infinity Neuro received CE-mark approval for its aspiration catheters from the European regulatory organization for the treatment of patients with hemorrhagic and ischemic stroke. Thus, the approval and launch of new devices used for diagnosing and treating patients suffering from various neurological diseases have been at the forefront recently. Due to technological advancements in artificial intelligence (AI) and software development in the last few years, the demand for software and services has increased in the healthcare sector, especially in the diagnosis and research field.

Software plays an important role in providing good image quality and facilitating health management to minimize the risk of treatment failure. In February 2023, Hyperfine, Inc. received U. S. FDA clearance for its upgraded AI-powered software. This software clearance implies the use of software that improves the image quality for diffusion-weighting imaging (DWI) of the brain. It is anticipated to boost the R&D of new software in the coming years and support market growth. Moreover, major players are acquiring companies to strengthen their market positions. This strategy enables companies to increase their capabilities, expand product portfolios, and improve competencies. For instance, in November 2022, Bruker Corp. acquired Inscopix, Inc. This acquisition strengthened Bruker’s position in the in-vivo brain function imaging portfolio, thereby driving market growth.

Neuroscience Market Report Highlights

  • In terms of components, the instrument segment dominated the market with a revenue share of 64.71% in 2022. This dominance can be attributed to the growing use of instruments during diagnostic and surgical procedures
  • In terms of technology, the brain-imaging segment dominated the industry with a share of 25.19% in 2022. This can be attributed to increased awareness among physicians about the importance of brain imaging in the diagnosis and treatment of neurological disorders
  • The diagnostic laboratories end-user segment dominated the industry with a revenue share of 42.04% in 2022. The increasing number of diagnostic centers engaged in neuroscience disease diagnosis is projected to fuel demand for devices, such as MRI and CT scans
  • North America held the largest revenue share of 31.42% in 2022. Technological advancements and high investment by the government and the adoption of advanced neuroscience devices are expected to drive the regional market growth
  • Strategic partnerships, major investments in R&D, and the development of new products or product modifications are the key strategies adopted by market players to increase the reach of their products and improve availability in diverse geographic areas

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Component
1.1.2. Technology
1.1.3. End-user
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. Component outlook
2.2.3. Technology outlook
2.2.4. End-user outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Neuroscience Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising disease burden of brain-associated disorders
3.2.1.2. Advancement in research for translation of neuroscience to neuro-technology
3.2.1.3. Increasing investments by the government for R&D activities
3.2.2. Market restraint analysis
3.2.2.1. High cost associated with neuroscience devices
3.2.2.2. Strict government regulations
3.3. Neuroscience Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Covid-19 Impact Analysis
Chapter 4. Neuroscience Market: Component Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Instruments
4.1.2. Consumables
4.1.3. Software & Services
4.2. Component Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Global Surgical Refractor Market by Component Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
4.5.1. Instruments
4.5.1.1. Instruments market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Consumables
4.5.2.1. Consumables market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Software & Services
4.5.3.1. Software & Services market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Neuroscience Market: Technology Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Brain Imaging
5.1.2. Neuro-Microscopy
5.1.3. Stereotaxic Surgeries
5.1.4. Neuro-Proteomic Analysis
5.1.5. Neuro-Cellular Manipulation
5.1.6. Others
5.2. Product Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Global Refractive Surgery Devices Market by Product Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
5.5.1. Brain Imaging
5.5.1.1. Brain imaging market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Neuro-Microscopy
5.5.2.1. Neuro microscopy market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Stereotaxic Surgeries
5.5.3.1. Stereotaxic surgeries market estimates and forecast 2018 to 2030 (USD Million)
5.5.4. Neuro-Proteomic Analysis
5.5.4.1. Neuro-proteomic Analysis market estimates and forecast 2018 to 2030 (USD Million)
5.5.5. Neuro-Cellular Manipulation
5.5.5.1. Neuro-cellular Manipulation market estimates and forecast 2018 to 2030 (USD Million)
5.5.6. Others
5.5.6.1. Other market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Neuroscience: End-user Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Diagnostic Laboratories
6.1.3. Research and Academic Institute
6.2. End-user Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. Global Refractive Surgery Devices Market by End-user Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Diagnostic laboratories
6.5.2.1. Diagnostic laboratories market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Research and Academic Institute
6.5.3.1. Research and academic institute market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Neuroscience Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2018 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2023 to 2030
7.5. North America
7.5.1. U.S.
7.5.1.1. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Canada market estimates and forecast, 2018 - 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. UK market estimates and forecast, 2018 - 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Germany market estimates and forecast, 2018 - 2030 (USD Million)
7.6.3. France
7.6.3.1. France market estimates and forecast, 2018 - 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Italy market estimates and forecast, 2018 - 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Spain market estimates and forecast, 2018 - 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Norway market estimates and forecast, 2018 - 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Japan market estimates and forecast, 2018 - 2030 (USD Million)
7.7.2. China
7.7.2.1. China market estimates and forecast, 2018 - 2030 (USD Million)
7.7.3. India
7.7.3.1. India market estimates and forecast, 2018 - 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Australia market estimates and forecast, 2018 - 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
7.9.3. UAE
7.9.3.1. UAE market estimates and forecast, 2018 - 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2022
8.3.4. Carl Zeiss AG
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Danaher Corporation
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. GE Healthcare
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Siemens Healthcare Private Limited
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Koninklijke Philips N.V.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Canon Inc.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. B. Braun SE
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Medtronic
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Stryker
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Boston Scientific Corporation
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. ABBOTT
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives
8.3.15. Terumo Corporation Terumo Corporation
8.3.15.1. Company overview
8.3.15.2. Financial performance
8.3.15.3. Product benchmarking
8.3.15.4. Strategic initiatives
List of Tables
Table 1 List of regulatory bodies for different countries
Table 2 Key companies’ product launches
Table 3 Key companies’ merger and acquisitions
Table 4 Key companies’ collaboration
Table 5 Other strategic initiatives of companies
Table 6 North America neuroscience market, by country, 2018 - 2030 (USD Million)
Table 7 North America neuroscience market, by component, 2018 - 2030 (USD Million)
Table 8 North America neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 9 North America neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 10 US neuroscience market, by component, 2018 - 2030 (USD Million)
Table 11 US neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 12 US neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 13 Canada neuroscience market, by component, 2018 - 2030 (USD Million)
Table 14 Canada neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 15 Canada neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 16 Europe neuroscience market, by country, 2018 - 2030 (USD Million)
Table 17 Europe neuroscience market, by component, 2018 - 2030 (USD Million)
Table 18 Europe neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 19 Europe neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 20 UK neuroscience market, by component, 2018 - 2030 (USD Million)
Table 21 UK neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 22 UK neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 23 Germany neuroscience market, by component, 2018 - 2030 (USD Million)
Table 24 Germany neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 25 Germany neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 26 France neuroscience market, by component, 2018 - 2030 (USD Million)
Table 27 France neuroscience market, by Technology, 2018 - 2030 (USD Million)
Table 28 France neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 29 Italy neuroscience market, by component, 2018 - 2030 (USD Million)
Table 30 Italy neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 31 Italy neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 32 Spain neuroscience market, by component, 2018 - 2030 (USD Million)
Table 33 Spain neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 34 Spain neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 35 Norway neuroscience market, by component, 2018 - 2030 (USD Million)
Table 36 Norway neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 37 Norway neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 38 Sweden neuroscience market, by component, 2018 - 2030 (USD Million)
Table 39 Sweden neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 40 Sweden neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 41 Denmark neuroscience market, by component, 2018 - 2030 (USD Million)
Table 42 Denmark neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 43 Denmark neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 44 Asia Pacific neuroscience market, by country, 2018 - 2030 (USD Million)
Table 45 Asia Pacific neuroscience market, by component, 2018 - 2030 (USD Million)
Table 46 Asia Pacific neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 47 Asia Pacific neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 48 Japan neuroscience market, by component, 2018 - 2030 (USD Million)
Table 49 Japan neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 50 Japan neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 51 China neuroscience market, by component, 2018 - 2030 (USD Million)
Table 52 China neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 53 China neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 54 India neuroscience market, by component, 2018 - 2030 (USD Million)
Table 55 India neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 56 India neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 57 Australia neuroscience market, by component, 2018 - 2030 (USD Million)
Table 58 Australia neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 59 Australia neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 60 South Korea neuroscience market, by component, 2018 - 2030 (USD Million)
Table 61 South Korea neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 62 South Korea neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 63 Thailand neuroscience market, by component, 2018 - 2030 (USD Million)
Table 64 Thailand neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 65 Thailand neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 66 Latin America neuroscience market, by country, 2018 - 2030 (USD Million)
Table 67 Latin America neuroscience market, by component, 2018 - 2030 (USD Million)
Table 68 Latin America neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 69 Latin America neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 70 Brazil neuroscience market, by component, 2018 - 2030 (USD Million)
Table 71 Brazil neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 72 Brazil neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 73 Mexico neuroscience market, by component, 2018 - 2030 (USD Million)
Table 74 Mexico neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 75 Mexico neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 76 Argentina neuroscience market, by component, 2018 - 2030 (USD Million)
Table 77 Argentina neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 78 Argentina neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa neuroscience market, by country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa neuroscience market, by component, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 83 South Africa neuroscience market, by component, 2018 - 2030 (USD Million)
Table 84 South Africa neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 85 South Africa neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia neuroscience market, by component, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 89 UAE neuroscience market, by component, 2018 - 2030 (USD Million)
Table 90 UAE neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 91 UAE neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 92 Kuwait neuroscience market, by component, 2018 - 2030 (USD Million)
Table 93 Kuwait neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 94 Kuwait neuroscience market, by end-user, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Neuroscience market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement process
Fig. 4 Primary research pattern
Fig. 5 Neuroscience market snapshot, 2022 (USD Million)
Fig. 6 Segment snapshot, USD Million
Fig. 7 Competitive landscape snapshot
Fig. 8 Penetration & growth prospect mapping, by product
Fig. 9 Market driver analysis (Current & future impact)
Fig. 10 Market restraint analysis (Current & future impact)
Fig. 11 Neuroscience market, Component outlook key takeaways (USD Million)
Fig. 12 Neuroscience market: Component movement analysis 2022 & 2030 (USD Million)
Fig. 13 Instruments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Consumables market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 Software & services market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 16 Neuroscience market, technology outlook key takeaways (USD Million)
Fig. 17 Neuroscience market: Technology movement analysis 2022 & 2030 (USD Million)
Fig. 18 Brain imaging market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Neuro-microscopy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Stereotaxic surgeries market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Neuro-proteomic analysis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Neuro-cellular manipulation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Neuroscience market, end-user outlook key takeaways (USD Million)
Fig. 25 Neuroscience market: End-user movement analysis 2022 & 2030 (USD Million)
Fig. 26 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Diagnostic laboratories market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Research and academic institute market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Neuroscience market: Regional key takeaways (USD Million)
Fig. 31 Neuroscience market: Regional outlook, 2022 & 2030 (USD Million)
Fig. 32 North America neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 US neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Canada neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Europe neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 UK neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Germany neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 France neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Spain neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Italy neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Sweden neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Norway neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Denmark neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Asia Pacific neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 China neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Japan neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 India neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 South Korea neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Australia neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Thailand neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Latin America neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Brazil neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Mexico neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Argentina neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Middle East and Africa neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 South Africa neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Saudi Arabia neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 UAE neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Kuwait neuroscience market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 List of key emerging company’s/technology disruptors/innovators

Companies Mentioned

  • Carl Zeiss AG
  • Danaher Corporation
  • GE Healthcare
  • Siemens Healthcare Private Limited
  • Koninklijke Philips N.V.
  • Canon Inc.
  • B. Braun SE
  • Medtronic
  • Stryker
  • Boston Scientific Corporation
  • ABBOTT
  • Terumo Corporation Terumo Corporation

Methodology

Loading
LOADING...

Table Information